University of California (San Francisco) Hematology and Medical Oncology

Topics

• Prostate Cancer Treatment and Research 433
• Multiple Myeloma Research and Treatments 374
• Prostate Cancer Diagnosis and Treatment 304
• Cancer Immunotherapy and Biomarkers 235
• CAR-T cell therapy research 227
• Acute Myeloid Leukemia Research 192
• Pancreatic and Hepatic Oncology Research 182
• Advanced Breast Cancer Therapies 173
• HER2/EGFR in Cancer Research 166
• Neuroendocrine Tumor Research Advances 157
• Cancer Genomics and Diagnostics 150
• Hepatocellular Carcinoma Treatment and Prognosis 143

Most cited

1. Hepatocellular carcinoma.

   Nature reviews. Disease primers · 2021 · 5,588 citations · Kate Kelley

2. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.

   Journal of hepatology · 2022 · 3,643 citations · Kate Kelley

3. Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.

   The New England journal of medicine · 2022 · 2,268 citations · Hope Rugo

4. Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology

   Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 922 citations · Matthew Gubens

5. BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update.

   Journal of hepatology · 2026 · 154 citations · Kate Kelley

6. Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma.

   NEJM evidence · 2022 · 1,418 citations · Kate Kelley

7. Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 1,255 citations ·